Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 APR 20 ... diagnosed each year. No cure has yet been found for ALS. There is one FDA approved drug, riluzole, that modestly slows the progression of ALS.
Quite a number of approaches ...
2009 JUN 8 ... appear to enhance immune restoration. In this study, we investigated the action of Riluzole (2-amino-6-trifuromethoxybenzothiazole) in HIV-1 infection....
2009 NOV 1 ... American Academy of Neurology. The guidelines recommend the use of the drug riluzole, the only FDA-approved drug for ALS, to slow the progression of the disease. ...
Subject: Louisiana State University Health Sciences Center
2009 OCT 12 ... the effects of central administration of minocycline (a tetracycline derivative) and riluzole (an antiglutamatergic drug) on morphine-induced tolerance in rats. Groups of rats ...
2009 NOV 1 ... percent survive for 10 or more years. According to the guidelines, the drug riluzole should be offered to people with ALS to slow the rate at which the disease progresses. ...
2009 OCT 19 ... Neurodegenerative Disease, Neurology, Pharmaceuticals, Regulatory Actions, Rilutek, Riluzole, Therapy, Treatment, U.S. Food and Drug Administration, Prize4Life. This ...
2009 NOV 23 ... analytes were extracted from human plasma by solid phase extraction." "Riluzole (RIL) was used as an internal standard for proguanil and cycloguanil. A HyPURITY Advance ...
2009 JUL 27 ... According to a study from the United States, "Riluzole is currently the only approved medication for amyotrophic lateral sclerosis (ALS). While ...
2009 AUG 31 ... oxidative stress strongly increases motoneuron excitability without eliciting bursting. Riluzole (the only drug currently licensed for the treatment of ALS) suppresses bursting of ...
2009 JUL 20 ... States report. "Furthermore, a xenograft model of melanoma treated with riluzole, an oral GRM1 blocking agent, showed decreased tumor growth compared with the untreated ...
2009 SEP 7 ... Na+ currents (I-NaP), achieved by NAc slice pre-incubation with 20 nm TTX or 10 mu m riluzole, significantly reduced the ADP amplitude, indicating that this type of Na+ current is ...
2009 AUG 31 ... with cell proliferation and cell death in human cancer cell lines. The effects of riluzole, an ion channel modulator, on cell proliferation, apoptosis and the apoptotic pathway in ...
2009 NOV 23 ... aggressive form of adult onset motor neuron degeneration. Despite intensive research, riluzole remains the only drug with proven efficacy," scientists writing in the journal Current ...
2009 APR 20 ... in the United States report.
"Since many patients are already on riluzole, it is important to ensure that any proposed therapy does not result in negative synergy ...
2009 MAY 25 ... fact, the impact of this genetic variant is comparable to the effect of the only drug (Riluzole) now approved for use in the United States. More importantly, this genetic variant may ...
Subject: University of Massachusetts Medical School
2009 SEP 7 ... with alcoholism," investigators in the United States report. "The drug riluzole, approved for treatment of amyotrophic lateral sclerosis (ALS), inhibits NMDA and ...
2009 MAY 11 ... abnormalities in OCD, new treatment approaches using glutamate modulator drugs such as riluzole, which is currently used for treating Lou Gehring's disease, and others have been ...
